Author/Authors :
J. K. Padia، نويسنده , , H. Chilvers، نويسنده , , P. Daum، نويسنده , , Willard R. Pinnock، نويسنده , , N. Suman-Chauhan، نويسنده , , L. webdale، نويسنده , , B. K. Trivedi، نويسنده ,
Abstract :
A novel hybrid series of nonpeptide CCK-B receptor antagonists has been designed from two known series derived from asperlicin. An efficient synthesis of 2-aminoquinazolinone, an intermediate for the synthesis of a targeted analog, has been developed.
